undamentalytics Newsletter
Sign in

Conmed Corp cash flow statement

In fiscal 2025, Conmed Corp's operations generated $171m of cash; it spent $19.8m on capital projects, leaving free cash flow of $151m. It returned $24.7m in dividends.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025
Cash from operations253810395816551406675956511233125167171
Depreciation and amortisation1917191919201920201919181616161717
Stock-based pay4456697881012131622242628
Capital spending2115182218151515131720131522191320
Free cash flow424857463503625535875529712106154151
Free cash flow after stock pay−1198068574028174448633881−1082128123
Dividends paid—001317222222222223232324252525
Share buybacks023154511700—————————

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: CNMD vs HAECNMD vs STVNCNMD vs PEN

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Conmed Corp's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Conmed Corp.